Hope Pharms Drug Patent Portfolio
Hope Pharms owns 3 orange book drugs protected by 7 US patents Given below is the list of Hope Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8568793 | Sodium nitrite-containing pharmaceutical compositions | 24 Dec, 2031 | Active |
| US8496973 | Sodium thiosulfate-containing pharmaceutical compositions | 29 Mar, 2031 | Active |
| US10479686 | Sodium thiosulfate-containing pharmaceutical compositions | 07 Jul, 2030 | Active |
| US9345724 | Sodium thiosulfate-containing pharmaceutical compositions | 07 Jul, 2030 | Active |
| US9585912 | Sodium thiosulfate-containing pharmaceutical compositions | 07 Jul, 2030 | Active |
| US11753301 | Sodium thiosulfate-containing pharmaceutical compositions | 10 Feb, 2030 | Active |
| US9687506 | Sodium nitrite-containing pharmaceutical compositions | 10 Feb, 2030 | Active |
Latest Legal Activities on Hope Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hope Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 22 Nov, 2023 | US9345724 |
| Recordation of Patent eGrant | 12 Sep, 2023 | US11753301 |
|
Email Notification
Critical
| 12 Sep, 2023 | US11753301 |
| Mail Patent eGrant Notification | 12 Sep, 2023 | US11753301 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Sep, 2023 | US11753301 |
| Patent eGrant Notification | 12 Sep, 2023 | US11753301 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Sep, 2023 | US11753301 |
|
Email Notification
Critical
| 24 Aug, 2023 | US11753301 |
|
Issue Notification Mailed
Critical
| 23 Aug, 2023 | US11753301 |
|
Application Is Considered Ready for Issue
Critical
| 02 Aug, 2023 | US11753301 |
| Dispatch to FDC | 02 Aug, 2023 | US11753301 |
|
Electronic Review
Critical
| 19 Jul, 2023 | US11753301 |
|
Email Notification
Critical
| 19 Jul, 2023 | US11753301 |
|
Issue Fee Payment Received
Critical
| 19 Jul, 2023 | US11753301 |
|
Issue Fee Payment Verified
Critical
| 19 Jul, 2023 | US11753301 |
Hope Pharms Drug Patents' Oppositions Filed in EPO
Hope Pharms drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jul 30, 2018, by Dr. Franz Köhler Chemie Gmbh. This opposition was filed on patent number EP10797770A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP10797770A | Jul, 2018 | Shimamura, Naomi | Patent maintained as amended |
| EP10797770A | Jul, 2018 | Dr. Franz Köhler Chemie GmbH | Patent maintained as amended |
Hope Pharms's Family Patents
Hope Pharms Drug List
Given below is the complete list of Hope Pharms's drugs and the patents protecting them.
1. Nithiodote
Nithiodote is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8568793 | Sodium nitrite-containing pharmaceutical compositions |
24 Dec, 2031
(7 years from now)
| Active |
| US8496973 | Sodium thiosulfate-containing pharmaceutical compositions |
29 Mar, 2031
(6 years from now)
| Active |
| US10479686 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US9345724 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US9585912 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US11753301 | Sodium thiosulfate-containing pharmaceutical compositions |
10 Feb, 2030
(5 years from now)
| Active |
| US9687506 | Sodium nitrite-containing pharmaceutical compositions |
10 Feb, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nithiodote's drug page
2. Sodium Nitrite
Sodium Nitrite is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8568793 | Sodium nitrite-containing pharmaceutical compositions |
24 Dec, 2031
(7 years from now)
| Active |
| US9687506 | Sodium nitrite-containing pharmaceutical compositions |
10 Feb, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sodium Nitrite's drug page
3. Sodium Thiosulfate
Sodium Thiosulfate is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8496973 | Sodium thiosulfate-containing pharmaceutical compositions |
29 Mar, 2031
(6 years from now)
| Active |
| US10479686 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US9345724 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US9585912 | Sodium thiosulfate-containing pharmaceutical compositions |
07 Jul, 2030
(5 years from now)
| Active |
| US11753301 | Sodium thiosulfate-containing pharmaceutical compositions |
10 Feb, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sodium Thiosulfate's drug page